Key PointsThe sale has nothing to do with the stock's potential, however.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.
Veytics Intelligence
Eli Lilly's Biggest Shareholder Is Selling $347 Million of Stock. Should You Sell Too?
